AtriCure, Inc. (ATRC)
56.84
+0.86
(+1.54%)
USD |
NASDAQ |
Nov 13, 16:00
56.84
0.00 (0.00%)
Pre-Market: 19:59
AtriCure Enterprise Value : 2.804B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 2.804B |
| November 12, 2026 | 2.760B |
| November 11, 2026 | 2.839B |
| November 10, 2026 | 2.774B |
| November 09, 2026 | 2.852B |
| November 06, 2026 | 2.890B |
| November 05, 2026 | 3.030B |
| November 04, 2026 | 3.246B |
| November 03, 2026 | 2.985B |
| November 02, 2026 | 2.958B |
| October 30, 2026 | 3.028B |
| October 29, 2026 | 3.091B |
| October 28, 2026 | 3.037B |
| October 27, 2026 | 3.041B |
| October 26, 2026 | 3.020B |
| October 23, 2026 | 2.912B |
| October 22, 2026 | 2.929B |
| October 21, 2026 | 2.846B |
| October 20, 2026 | 2.846B |
| October 19, 2026 | 2.737B |
| October 16, 2026 | 2.764B |
| October 15, 2026 | 2.852B |
| October 14, 2026 | 2.827B |
| October 13, 2026 | 2.805B |
| October 12, 2026 | 2.826B |
| Date | Value |
|---|---|
| October 09, 2026 | 2.751B |
| October 08, 2026 | 2.600B |
| October 07, 2026 | 2.624B |
| October 06, 2026 | 2.643B |
| October 05, 2026 | 2.780B |
| October 02, 2026 | 2.717B |
| October 01, 2026 | 2.638B |
| September 30, 2026 | 2.771B |
| September 29, 2026 | 2.859B |
| September 28, 2026 | 2.877B |
| September 25, 2026 | 2.876B |
| September 24, 2026 | 2.997B |
| September 23, 2026 | 2.956B |
| September 22, 2026 | 2.899B |
| September 21, 2026 | 2.873B |
| September 18, 2026 | 2.862B |
| September 17, 2026 | 2.913B |
| September 16, 2026 | 2.813B |
| September 15, 2026 | 2.766B |
| September 14, 2026 | 2.744B |
| September 11, 2026 | 2.681B |
| September 10, 2026 | 2.600B |
| September 09, 2026 | 2.604B |
| September 08, 2026 | 2.639B |
| September 04, 2026 | 2.527B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 215.41B |
| Boston Scientific Corp. | 75.80B |
| AngioDynamics, Inc. | 480.34M |
| Alphatec Holdings, Inc. | 1.622B |
| Baxter International, Inc. | 19.36B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 4.064M |
| Revenue (Quarterly) | 154.45M |
| Total Expenses (Quarterly) | 150.39M |
| EPS Diluted (Quarterly) | 0.0816 |
| Gross Profit Margin (Quarterly) | 76.80% |
| Profit Margin (Quarterly) | 2.63% |
| Earnings Yield | 0.53% |
| Operating Earnings Yield | 0.65% |
| Normalized Earnings Yield | 0.5598 |